Peer-to-peer file sharing

UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds

Retrieved on: 
Friday, November 10, 2023
Sale, SAN, Security (finance), Form, Exercise, Peer-to-peer file sharing, Clinical trial, Biotechnology, Therapy, UBX, Ageing, Unity Biotechnology

The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-3 (File No.

Key Points: 
  • The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-3 (File No.
  • The gross proceeds to UNITY from the exercise of the warrants are expected to be approximately $4.38 million, prior to deducting placement agent fees and offering expenses.
  • In consideration for the immediate exercise of the warrants for cash, UNITY will issue new unregistered warrants to purchase up to 2,143,000 shares of common stock.
  • UNITY has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants.

BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Retrieved on: 
Thursday, November 9, 2023
Sale, Peer-to-peer file sharing, Security (finance), Nautilus, Inc. v. Biosig Instruments, Inc., Park, Telephone, Form, Exercise, Prospectus, Series

The gross proceeds from the offering are expected to be approximately $2.5 million.

Key Points: 
  • The gross proceeds from the offering are expected to be approximately $2.5 million.
  • BioSig intends to use the net proceeds of this offering for working capital and general corporate purposes.
  • The securities described above are being offered by BioSig pursuant to a shelf registration statement on Form S-3 (File No.
  • The securities offered in the registered direct offering are being offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement.

Orgenesis Inc. Announces Pricing of $1.1 Million Registered Direct Offering

Retrieved on: 
Wednesday, November 8, 2023
Titan, Sale, Peer-to-peer file sharing, Security (finance), Telephone, Form, Bangladesh Securities and Exchange Commission, Warrant, CVC Capital Partners, Prospectus, CGT, S-3

The combined effective purchase price for each share of common stock and associated warrant to purchase one share of common stock will be $0.78.

Key Points: 
  • The combined effective purchase price for each share of common stock and associated warrant to purchase one share of common stock will be $0.78.
  • Under the terms of the securities purchase agreement, Orgenesis has agreed to issue 1,410,256 shares of common stock and warrants to purchase up to an aggregate of 1,410,256 shares of common stock (the “Warrants”).
  • Titan Partners Group, a division of American Capital Partners, is acting as sole placement agent for the offering.
  • The offering is expected to close on or about November 9, 2023, subject to the satisfaction of customary closing conditions.

Longeveron Announces Closing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Retrieved on: 
Friday, October 13, 2023
Park Avenue, Security (finance), Public expenditure, Prospectus, Bangladesh Securities and Exchange Commission, Peer-to-peer file sharing, Form, Regulation D, 3rd Floor, Hypoplastic left heart syndrome, HLHS, Sale

The Series A Warrants and Series B Warrants have terms of five and one-half years and eighteen months from the date of issuance, respectively.

Key Points: 
  • The Series A Warrants and Series B Warrants have terms of five and one-half years and eighteen months from the date of issuance, respectively.
  • H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
  • The gross proceeds to Longeveron from the offering are approximately $4 million, before deducting the placement agent’s fees and other offering expenses payable by Longeveron.
  • A final prospectus supplement and accompanying prospectus relating to the registered direct offering was filed with the SEC on October 13, 2023.

Kineta, Inc. Announces Closing of $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Retrieved on: 
Thursday, October 5, 2023
Park Avenue, Form S-3, Prospectus, Peer-to-peer file sharing, Cancer, Form, Regulation D, 3rd Floor, Kineta, Security (finance), Sale

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

Key Points: 
  • H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
  • The gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, were approximately $3 million.
  • The Company intends to use the net proceeds from this offering for working capital purposes.
  • A final prospectus supplement and accompanying prospectus relating to the registered direct offering were filed with the SEC.

Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Retrieved on: 
Wednesday, October 4, 2023
Park Avenue, Cancer, Peer-to-peer file sharing, Regulation D, Sale, Kineta, 3rd Floor, Prospectus, Form, Security (finance)

The closing of the offering is expected to occur on or about October 5, 2023, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about October 5, 2023, subject to the satisfaction of customary closing conditions.
  • H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
  • The gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, are expected to be approximately $3 million.
  • A final prospectus supplement and accompanying prospectus relating to the registered direct offering will be filed with the SEC.

Checkpoint Therapeutics Announces Exercise of Warrants for $11.13 Million in Gross Proceeds

Retrieved on: 
Monday, October 2, 2023
Exercise, Checkpoint, CKPT, Peer-to-peer file sharing, Bangladesh Securities and Exchange Commission, Sale, Form S-3, Series, Form, Security (finance)

The shares of common stock issuable upon exercise of the warrants are registered pursuant to effective registration statements on Form S-3 (File No.

Key Points: 
  • The shares of common stock issuable upon exercise of the warrants are registered pursuant to effective registration statements on Form S-3 (File No.
  • The gross proceeds to Checkpoint from the exercise of the warrants are expected to be approximately $11.13 million, prior to deducting placement agent fees and estimated offering expenses.
  • In consideration for the immediate exercise of the warrants for cash, Checkpoint will issue new unregistered Series A warrants to purchase up to 6,325,354 shares of common stock and new unregistered Series B warrants to purchase up to 6,325,354 shares of common stock.
  • Checkpoint has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants.

Portage Biotech Announces $6.0 Million Registered Direct Offering

Retrieved on: 
Friday, September 29, 2023
Act, Park Avenue, Peer-to-peer file sharing, Regulation D, Securities and Exchange Commission (Philippines), Sale, PRTG, 3rd Floor, Form, Security (finance)

The closing of the offering is expected to occur on or about October 3, 2023, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about October 3, 2023, subject to the satisfaction of customary closing conditions.
  • The gross proceeds to the Company from the offering are expected to be approximately $6.0 million, before deducting the placement agent’s fees and other offering expenses payable by the Company.
  • The offering of such securities in the registered direct offering is being made only by means of a base prospectus and prospectus supplement that forms a part of the effective registration statement.
  • A final prospectus supplement and the accompanying base prospectus relating to the registered direct offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov.

First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.0 Million Gross Proceeds Priced At-the-Market

Retrieved on: 
Thursday, September 14, 2023
Exercise, BOCA, Peer-to-peer file sharing, Sale, Form S-1, Form S-3, Form, Security (finance), Roth Capital Partners

The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $4.0 million, before deducting financial advisory fees.

Key Points: 
  • The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $4.0 million, before deducting financial advisory fees.
  • The reduction in the exercise price of the existing warrants and the issuance of the new warrants was structured as an at-market transaction under Nasdaq rules.
  • The shares of common stock issuable upon exercise of the warrants are registered pursuant to a registration statement on Form S-3 (File No.
  • The securities offered in the private placement have not been registered under the Securities Act of 1933, as amended, or applicable under state securities laws.

Profound Medical Announces At-the-Market Offering of up to US$30,000,000

Retrieved on: 
Thursday, September 7, 2023
Standby Equity Distribution Agreement, Toronto Stock Exchange, Telephone, Peer-to-peer file sharing, Unit, EDGAR, Sale, Register, Agent, Offering, Intermediary, United States Army Medical Corps, Indian stock exchange, Form, TSX, Security (finance), Registration statement, Bank

The volume and timing of distributions under the ATM Program will be determined at the Company’s discretion.

Key Points: 
  • The volume and timing of distributions under the ATM Program will be determined at the Company’s discretion.
  • 333-263248) (the “Registration Statement”), filed with the U.S. Securities and Exchange Commission under the U.S. Securities Act of 1933, as amended.
  • The timing and extent of the use of the ATM Program will be at the discretion of the Company.
  • Copies of the Distribution Agreement, the Prospectus Supplement and the Base Shelf Prospectus are available on SEDAR+ at www.sedarplus.ca and the Distribution Agreement, the U.S.